Cooley Represents Molecular Partners in Broad Collaboration with Allergan

San Diego, Calif. – September 10, 2012 – Cooley LLP announced that it represented Switzerland-based Molecular Partners as the company expanded its existing collaboration relationship with Allergan.  The companies entered into two separate agreements to discover, develop and commercialize proprietary therapeutic DARPin® products for the treatment of serious ophthalmic diseases.

Molecular Partners will receive a total upfront payment of $62.5 million and is eligible to receive additional success-based payments, including up to $1.4 billion in aggregate development, regulatory and sales milestones, and tiered royalties up into the low double-digits for future product sales.

The first agreement is an exclusive license agreement for the design, development and commercialization of a potent dual anti-VEGF-A/PDGF-B DARPin® ("MP0260") and its corresponding backups for the treatment of age-related macular degeneration and related conditions.  The second agreement is an exclusive discovery alliance agreement under which the parties will collaborate to design and develop DARPins against multiple targets that are implicated in causing serious diseases of the eye.  The complete announcement can be found here.

The Cooley team representing Molecular Partners included partner Ken Krisko, and associates Noelle Sitthikul and Rena Kaminsky.

About Cooley LLP

Cooley's attorneys have an entrepreneurial spirit, substantive experience and are committed to solving clients' most challenging legal matters.  From small companies with big ideas to international enterprises with diverse legal needs, Cooley has the breadth of legal resources to enable companies of all sizes to seize opportunities in today's global marketplace. The firm represents clients across a broad array of dynamic industry sectors, including technology, life sciences, venture capital, clean energy, real estate and retail.

The firm has full-service offices in eleven major business and technology centers: Boston, MA; Broomfield, CO; Los Angeles, CA; New York, NY; Palo Alto, CA; Reston, VA; San Diego, CA; San Francisco, CA; Seattle, WA; Washington, DC; and Shanghai, China.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.